Validation of a Treadmill Walking Test to Discriminate Neurogenic Claudication From Vascular Claudication
Launched by UNIVERSITÉ DU QUÉBEC À TROIS-RIVIÈRES · Aug 13, 2019
Trial Information
Current as of June 09, 2025
Completed
Keywords
ClinConnect Summary
To date, an important challenge that clinicians hare facing in the assessment and diagnosis of intermittent claudication is that pathologies associated with vascular or neurogenic claudication can coexist in the same patient. Differentiation between both origins can be difficult due to variable signs and symptoms which can be atypical.
The first aim of this study was to elaborate and validate a treadmill walking test that would help discriminate between neurogenic claudication from vascular claudication. The second objective of this study is to determine if the treadmill walking test can d...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Lumbar spinal stenosis (LSS) group :
- • Central stenosis
- • Pain in at least one leg
- • Neurological signs in the lower limbs (numbness or tingling)
- • Weaknesses in the lower limb
- • Pain relieved by sitting or bending the trunk
- Peripheral artery disease (PAD) group :
- • Claudication while walking
- • Ankle-brachial index \< 0.9
- • Pain relieved by rest
- Low back pain (LBP) :
- • Pain radiating in the lower limb
- • Weaknesses
- • Pain relieved by sitting
- Exclusion Criteria:
- • Foraminal stenosis
- • Spinal stenosis with predominant back pain
- • Symptomatic disc herniation
- • Previous lumbar surgery
- • Previous vascular surgery
- • Type 1 diabetes
- • Knee or hip osteoarthritis
- • Hip or knee arthroplasty
- • Inability to provide free and informed consent
About Université Du Québec à Trois Rivières
Université du Québec à Trois-Rivières (UQTR) is a leading academic institution dedicated to advancing research and education in various fields, including health sciences. With a commitment to innovation and interdisciplinary collaboration, UQTR fosters an environment conducive to groundbreaking clinical trials aimed at improving patient outcomes and enhancing healthcare practices. The university's robust research infrastructure and skilled faculty support the design and implementation of high-quality clinical studies, ensuring adherence to ethical standards and regulatory compliance. UQTR's involvement in clinical trials underscores its mission to contribute significantly to scientific knowledge and the betterment of community health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Trois Rivières, Quebec, Canada
Patients applied
Trial Officials
Martin Descarreaux, DC, PhD
Study Director
Université du Québec à Trois-Rivières
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials